INTRAVITREAL RANIBIZUMAB FOR DIABETIC MACULAR OEDEMA - A RETROSPECTIVE REVIEW OF 12 MONTH FOLLOW UP DATA AT THE MANCHESTER ROYAL EYE HOSPITAL (MREH), UK

被引：0
|
作者：
Subramani, S. [1 ]
Stone, A. [1 ]
机构：
[1] Manchester Royal Eye Hosp, Manchester, Lancs, England
来源：
EUROPEAN JOURNAL OF OPHTHALMOLOGY | 2016年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E89 / E89
页数：1
相关论文
共 14 条
  • [1] A RETROSPECTIVE REVIEW OF CLINICAL OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR DIABETIC MACULAR OEDEMA (DMO) IN TREATMENT NAIVE PATIENTS WITH THOSE SWITCHED FROM ALTERNATIVE THERAPIES OVER 12 MONTHS AT MANCHESTER ROYAL EYE HOSPITAL (MREH)
    Jasani, K.
    D'Souza, Y.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (03) : E128 - E128
  • [2] INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF DIABETIC MACULAR OEDEMA: REAL-LIFE 12 MONTH RESULTS
    Zacharaki, F.
    Chandran, M.
    Menon, G. V.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2016, 26 (04) : E109 - E109
  • [3] Effects of the treatment with intravitreal injection of Ranibizumab for Diabetic Macular Edema. Our Experience: 30 month Follow up
    Comastri, Lucia
    Iglicki, Matias
    Pablo Francos, Juan
    Manuel Cortalezzi, Juan
    Bar, Diego
    Demetrio, Carmen N.
    Saravia, Mario J.
    Bar, Jorge
    Chiaradia, Pablo
    Zas, Marcelo
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [4] Retinal-choroidal changes after intravitreal ranibizumab in diabetic macular edema: 12 months follow-up
    Giorno, Paola
    Parravano, Mariacristina
    Oddone, Francesco
    Cacciamani, Andrea
    Scarinci, Fabio
    Boninfante, Antonluca
    Varano, Monica
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [5] Efficacy and safety of the intravitreal treatment of Diabetic Macular Edema with Pegaptanib: a 12-month follow-up
    Pacella, E.
    La Torre, G.
    Impallara, D.
    Malarska, K.
    Turchetti, P.
    Brillante, C.
    Smaldone, G.
    De Paolis, G.
    Muscella, R.
    Pacella, F.
    [J]. CLINICA TERAPEUTICA, 2013, 164 (02): : E121 - E126
  • [6] The impact of compliance among patients with diabetic macular oedema treated with intravitreal aflibercept: a 48-month follow-up study
    Angermann, Reinhard
    Hofer, Markus
    Huber, Anna Lena
    Rauchegger, Teresa
    Nowosielski, Yvonne
    Casazza, Marina
    Falanga, Valeria
    Zehetner, Claus
    [J]. ACTA OPHTHALMOLOGICA, 2022, 100 (02) : E546 - E552
  • [7] Changes in glycosylated haemoglobin in patients with diabetic macular oedema under long-term follow-up and treatment with repeat injections of intravitreal ranibizumab
    Mohamed, Q.
    Kirk, J.
    Stratton, I. M.
    Johnson, R.
    Scanlon, P.
    [J]. DIABETIC MEDICINE, 2015, 32 : 190 - 190
  • [8] Intravitreal Ranibizumab Alone or in Combination with Calcium Dobesilate for the Treatment of Diabetic Macular Edema in Nonproliferative Diabetic Retinopathy Patients: 12-Month Outcomes of a Retrospective Study
    Wang, Dongxuan
    Wang, Hui
    Wu, Shuang
    Yang, Xueqiu
    Xu, Jiansen
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022, 2022
  • [9] Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes
    Sivaprasad, Sobha
    Ghanchi, Faruque
    Kelly, Simon P.
    Kotagiri, Ajay
    Talks, James
    Scanlon, Peter
    McGoey, Hellen
    Nolan, Andrew
    Saddiq, Moneeb
    Napier, Jackie
    [J]. EYE, 2022, 36 (01) : 64 - 71
  • [10] Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes
    Sobha Sivaprasad
    Faruque Ghanchi
    Simon P. Kelly
    Ajay Kotagiri
    James Talks
    Peter Scanlon
    Hellen McGoey
    Andrew Nolan
    Moneeb Saddiq
    Jackie Napier
    [J]. Eye, 2022, 36 : 64 - 71
12